Helicore Biopharma Company Profile, Contacts & Intelligence

Helicore Biopharma Overview

Helicore Biopharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics to address obesity and related metabolic conditions. The company is advancing a portfolio of next-generation treatments with a novel approach to glucose-dependent insulinotropic peptide (GIP) antagonism. Helicore’s proprietary platform leverages monoclonal antibodies that bind circulating GIP ligand, designed to improve the efficacy, dosing, and tolerability of anti-obesity therapies. Helicore is rapidly advancing a differentiated portfolio that may deliver superior treatment outcomes through enhanced efficacy, tolerability and convenient dosing regimens. Following the close of a $65M Series A financing in January 2024, Helicore is well-positioned to drive progress in this critical area of unmet need. For more information, visit www.helicore.com.

Headquarters

San Mateo, California, United States

Website

www.helicore.com

Industry

Biotechnology Research

Founded

2025

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Helicore Biopharma Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Helicore Biopharma People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Helicore Biopharma

Explore companies in related markets and compare their industry and employee estimates.